FdaApplication
ANDA 216135
Identifiers
- fda_app_no: ANDA216135
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2024-07-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZINC SULFATE | ZINC SULFATE | EQ 25MG BASE/5ML (EQ 5MG BASE/ML) | SOLUTION;INTRAVENOUS |
| ZINC SULFATE | ZINC SULFATE | EQ 30MG BASE/10ML (EQ 3MG BASE/ML) | SOLUTION;INTRAVENOUS |
2 products